[Three Cases of Resectable Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy].

Sato, Nariatsu; Nakayama, Akira; Takai, Yuki; Kono, Tatsuhiko; Kamata, Toru; Kanno, Masahiro

Sato, Nariatsu; Nakayama, Akira; Takai, Yuki; Kono, Tatsuhiko; Kamata, Toru; Kanno, Masahiro.

Afiliación

Sato N; Dept. of Digestive Surgery, Keiju Medical Center.

Gan To Kagaku Ryoho ; 45(13): 2060-2062, 2018 Dec.

Article en Ja | MEDLINE | ID: mdl-30692284

RESUMEN

Three patients diagnosed with HER2-negative resectable advanced gastric cancer with extensive regional lymph node metastases were treated with neoadjuvant chemotherapy(NAC), followed by gastrectomy with D2lymph node dissection. One patient received four 21-day courses of S-1 plus oxaliplatin(G-SOX), and pathological effect(PE)was Grade 3. Two patients received four 21-day courses of capecitabine plus oxaliplatin(CapeOX), and each PE was Grade 2and Grade 1a, respectively. One patient in poor PE was with recurrent liver and peritoneal metastases. This suggested that for resectable advanced gastric cancer with extensive regional lymph node metastases, NAC by SOX or CapeOX was effective for some patients.

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica; Neoplasias Gástricas; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Combinación de Medicamentos; Gastrectomía; Humanos; Terapia Neoadyuvante; Ácido Oxónico/administración & dosificación; Neoplasias Gástricas/tratamiento farmacológico; Neoplasias Gástricas/cirugía; Tegafur/administración & dosificación

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Humans Idioma: Ja Revista: Gan To Kagaku Ryoho Año: 2018 Tipo del documento: Article Pais de publicación: Japón

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links